BC
Brian M Culley
President and CEO

Brian M Culley insider trades: Lineage Cell Therapeutics (LCTX) stock buys and sales

President and CEO, Lineage Cell Therapeutics Last trade Mar 12, 2026 57 Form 4 filings
$0
Sold, last 12 months
0 sales
$24K
Bought, last 12 months
1 buy
11
Open-market trades
since 2010
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brian reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 12, 2026LCTX↑ Buy$24K
Nov 21, 2024LCTX↑ Buy$24K
May 24, 2024LCTX↑ Buy$11K
Mar 31, 2022LCTX↑ Buy$10K
Mar 25, 2022LCTX↑ Buy$7K
Jun 28, 2021LCTX↓ Sell$1.3M
Aug 13, 2019LCTX↑ Buy$10K
Mar 14, 2012ANX↑ Buy$12K
Mar 13, 2012ANX↑ Buy$8K
Jun 2, 2011[ANX]↓ Sell$12K
May 27, 2010ANX↑ Buy$9K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Brian M Culley's insider trades

Brian M Culley is President and CEO at Lineage Cell Therapeutics (LCTX). Since May 27, 2010, Brian has reported 9 open-market purchases worth $116K and 2 sales worth $1.3M on SEC Form 4. In the last 12 months: 1 buy ($24K).

Their filings also include grants and awards (29 filings), shares withheld for taxes (19 filings), option exercises (18 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LCTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.